Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Uveitis, Anterior

1-methyl-3-isobutylxanthine has been researched along with Uveitis, Anterior in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Uveitis, Anterior: Inflammation of the anterior uvea comprising the iris, angle structures, and the ciliary body. Manifestations of this disorder include ciliary injection, exudation into the anterior chamber, iris changes, and adhesions between the iris and lens (posterior synechiae). Intraocular pressure may be increased or reduced.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verbey, NL1
van Haeringen, NJ1
de Jong, PT1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Uveitis, Anterior

ArticleYear
The effects of 3-isobutyl-methyl-xanthine on experimentally induced ocular inflammation in the rabbit.
    Current eye research, 1988, Volume: 7, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Aqueous Humor; Ascorbic Acid; Dinoprostone; Eye Proteins; Immu

1988